Hope Therapeutics announces Kadima Neuropsychiatry Institute as the expected first acquisition for its international ...
HOPE Therapeutics, Inc., a medical and technology driven company, and a wholly-owned subsidiary of NRx Pharmaceuticals, Inc. (NRx), announced the planned acquisition of the Kadima Neuropsychiatry Institute (Kadima) of La Jolla, California, per the …